Recruiting Bipolar Disorder Studies in Imperial
ALTO-100 in Bipolar Disorder With Depression (BD-D)
The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II with current major depr...
Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. This study will assess how safe and effective ABBV-932 is in treating participant...
About Bipolar Disorder Clinical Trials in Imperial
Bipolar disorder is a mental health condition marked by extreme mood swings including emotional highs (mania or hypomania) and lows (depression). It affects about 2.8% of adults in the U.S. Treatment typically involves mood stabilizers, antipsychotics, and psychotherapy.
There are currently 2 bipolar disorder clinical trials recruiting participants in Imperial, CALIFORNIA. These studies are seeking a combined 360 participants. Research is being sponsored by Alto Neuroscience, AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bipolar Disorder Clinical Trials in Imperial — FAQ
Are there bipolar disorder clinical trials in Imperial?
Yes, there are 2 bipolar disorder clinical trials currently recruiting in Imperial, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Imperial?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Imperial research site will contact you about next steps.
Are clinical trials in Imperial free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Imperial studies also compensate for your time and travel.
What bipolar disorder treatments are being tested?
The 2 active trials in Imperial are testing new therapies including novel drugs, biologics, and treatment approaches for bipolar disorder.
Data updated March 2, 2026 from ClinicalTrials.gov